Dr. Jennifer McVean, MD, stands at the forefront of pediatric diabetes care, blending her personal journey with Type 1 Diabetes and extensive medical expertise to transform the lives of children and families affected by this condition. Diagnosed at age 11, Dr. McVean’s firsthand experience fuels her compassionate approach and relentless pursuit of innovative treatments.
After earning her medical degree from the University of Minnesota Medical School, Dr. McVean completed her pediatric residency at the University of Colorado and a fellowship in Pediatric Endocrinology and Diabetes at the University of Wisconsin. She is board-certified in both Pediatrics and Pediatric Endocrinology.
Throughout her career, Dr. McVean has held pivotal roles at esteemed institutions, including the University of Minnesota, Children’s Minnesota, and Gundersen Health System. Currently, she serves as the Senior Director of Medical Affairs for Medtronic Diabetes, where she leads efforts to advance diabetes technology and improve patient outcomes.
Dr. McVean’s research has significantly contributed to the understanding and management of pediatric diabetes. Notably, she co-authored a study published in JAMA titled “Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial.” This research explores how near-normalization of glucose levels immediately after diagnosis can preserve pancreatic beta cell function by reducing glucotoxicity.
In another study, “Factors Correlating with Improved A1C in Children Using Continuous Subcutaneous Insulin Infusion,” Dr. McVean examined variables associated with better glycemic control in pediatric patients utilizing insulin pumps.
Beyond her clinical and research endeavors, Dr. McVean is deeply involved in diabetes advocacy and education. She has collaborated with organizations such as the Juvenile Diabetes Research Foundation (JDRF) and the American Diabetes Association (ADA), dedicating her time to mentoring, community outreach, and advancing public awareness about diabetes prevention and treatment.
Dr. Jennifer McVean has become a respected voice in the Type 1 Diabetes community through her leadership, advocacy, and commitment to advancing diabetes care. Living with Type 1 Diabetes herself, Dr. McVean brings both personal experience and medical expertise to the search for better treatments and, ultimately, a cure.
Her work has helped accelerate awareness of emerging disease-modifying therapies, early detection programs, advanced insulin delivery systems, and next-generation cell-based treatments that are changing the future of Type 1 Diabetes care. Researchers worldwide are now making significant progress toward therapies that may delay, prevent, or one day eliminate the need for lifelong insulin dependence.
As a physician, educator, and advocate, Dr. McVean continues to support groundbreaking research efforts aimed at preserving insulin-producing cells, improving quality of life, and moving the medical community closer to a world without Type 1 Diabetes. While no definitive cure has yet been approved, the pace of innovation has never been greater, and leaders like Dr. McVean are helping drive that progress forward.
For more information about Dr. Jennifer McVean and her contributions to pediatric diabetes care, visit her profile at Hudson Physicians.